Testing effectiveness (Phase 2)Ended earlyNCT01120158What this trial is testingPaclitaxel Plus Bevacizumab for Older Patients With Breast CancerWho this might be right forBreast Cancer Hellenic Oncology Research Group 46
Large-scale testing (Phase 3)Study completedNCT04799249What this trial is testingTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)Who this might be right forTNBC - Triple-Negative Breast CancerBreast Cancer G1 Therapeutics, Inc. 194
Large-scale testing (Phase 3)UnknownNCT03423849What this trial is testingThe Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyWho this might be right forBreast CancerChemotherapy EffectDisease-free Survival Zhiyong Yu 200
Testing effectiveness (Phase 2)WithdrawnNCT05966233What this trial is testingR-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent Fondazione Italiana Linfomi - ETS
Not applicableStudy completedNCT06432933What this trial is testingComparison of Apnea-Hypopnea Index in Patients With or Without Preventive Oxygen Therapy After Bariatric SurgeryWho this might be right forObstructive Sleep ApneaObesityBariatric Surgery Candidate Rijnstate Hospital 153
Testing effectiveness (Phase 2)Study completedNCT03109158What this trial is testingNC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forCarcinoma, Squamous Cell of Head and Neck NanoCarrier Co., Ltd. 1
Post-approval studies (Phase 4)UnknownNCT04667299What this trial is testingBismuth-Metronidazole Triple Therapy for H. Pylori First-line TreatmentWho this might be right forHelicobacter Pylori Infection Shanghai Zhongshan Hospital 270
Not applicableLooking for participantsNCT06561399What this trial is testingTriple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)Who this might be right forHepatocellular Carcinoma Non-resectable Fujian Provincial Hospital 28
Early research (Phase 1)Not Yet RecruitingNCT07254793What this trial is testingProphylactic and Therapeutic DLI-X for Leukemia Relapse After HCTWho this might be right forAcute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more University of Arizona 94
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02176031What this trial is testingPhase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHDWho this might be right forGraft Versus Host Disease Dana-Farber Cancer Institute 21
Not applicableUnknownNCT02323802What this trial is testingDiet Therapy Versus Prescriptive Educational Group Intervention in Overweight / Obese Patients at First Episode of AMI: a Randomized Controlled TrialWho this might be right forObesity /OverweightAcute Myocardial Infarction (STEMI/ NSTEMI) Fondazione IRCCS Policlinico San Matteo di Pavia 90
Not applicableLooking for participantsNCT06827353What this trial is testingNiraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination DeficiencyWho this might be right forOvarian Carcinoma Centre Hospitalier Universitaire de Nīmes 300
Testing effectiveness (Phase 2)Study completedNCT03780257What this trial is testingStudy to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A GeneWho this might be right forRetinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more ProQR Therapeutics 20
Not applicableWithdrawnNCT00425581What this trial is testingN-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of LifeWho this might be right forHypotensionVery Low Birth Weight InfantsVentricular Dysfunction+1 more Sheba Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT03007992What this trial is testingMetronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerWho this might be right forMetastatic Breast Cancer Johannes Gutenberg University Mainz 9
Large-scale testing (Phase 3)Study completedNCT01764022What this trial is testingA Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer PatientsWho this might be right forHuman Epithelial Receptor (HER)-2 Positive Breast Cancer Biocad 225
Not applicableNot Yet RecruitingNCT07788651What this trial is testingVideo-based First-contact Physiotherapy in Primary CareWho this might be right forMusculoskeletal Diseases Vastra Gotaland Region 208
Testing effectiveness (Phase 2)UnknownNCT02525237What this trial is testingApatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric CancerWho this might be right forGastric Cancer Qingdao Municipal Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02593175What this trial is testingWomen's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCWho this might be right forStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+8 more M.D. Anderson Cancer Center 43